Radboudumc and Eindhoven University of Technology present: BIOTRIP. This independent biotech incubator aims to ensure human health through cutting edge biotech. BIOTRIP is a unique platform that brings together medical scientists and entrepreneurial biomedical engineers to work with biotech entrepreneurs. They develop, commercialize and make available vaccines and immunotherapies to patients with a variety of diseases.
Related news items
Teaming up to develop an effective cure for mycobacterium abscessus disease using inhaled tigecycline
7 July 2021PureIMS, Radboudumc, and Sever Pharma Solutions are now teaming up to develop an effective cure for this chronic and debilitating disease.
read more
First volunteers vaccinated with Radboudumc malaria vaccine
20 May 2021Today a new vaccine against malaria, largely developed in Nijmegen, is being tested for the first time in volunteers at Radboudumc.
read more
Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection
17 February 2021In a review in Cell Mihai Netea, Frank van de Veerdonk, Reinout van Crevel and Jorge Dominguez Andres propose that induction of trained immunity by whole-microorganism vaccines may represent an important tool for reducing susceptibility to and severity of SARS-CoV-2.
read more
Two studies show potential of trained immunity for the treatment of cancer Radboudumc makes Cell twice in one issue
29 October 2020Mihai Netea: "These studies show that stimulating trained immunity can have an important anti-cancer effect. In combination with current immunotherapy with 'checkpoint inhibitors', boosting trained immunity has the potential to significantly improve cancer treatment"
read more
Radboudumc and Radboud University strengthen collaboration with Janssen
17 March 2019On March 12, Radboudumc and Radboud University have signed a letter of intent for intensified collaboration with Janssen.
read more